Filing Details
- Accession Number:
- 0001131399-10-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-30 12:13:21
- Reporting Period:
- 2010-11-29
- Filing Date:
- 2010-11-30
- Accepted Time:
- 2010-11-30 12:13:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1080014 | Theravance Inc | THRX | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1131399 | Plc Glaxosmithkline | 980 Great West Road Brentford Middlesex X0 TW8 9GS | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-11-29 | 5,750,000 | $22.50 | 5,750,000 | No | 4 | P | Indirect | by Corporation |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | by Corporation |
Footnotes
- The amount of Common Stock reported as beneficially owned by the Reporting Person following the reported transaction does not include the Reporting Person's previously disclosed beneficial ownership of 9,401,499 shares of Class A Common Stock of Theravance,Inc. (the "Class A Common Stock"), which are held of record by GlaxoSmithKline LLC and Glaxo Group Limited ("GGL"), each of which is a wholly-owned subsidiary of the Reporting Person. Each share of Class A Common Stock may be converted into one share of Common Stock at any time.
- Shares of Common Stock are held of record by GGL.
Billionaire Hedge Funds
